PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,404,000 | +311.6% | 27,500 | +75.3% | 0.03% | +312.5% |
| Q1 2017 | $584,000 | +21.2% | 15,690 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $482,000 | -91.5% | 15,690 | -81.4% | 0.01% | -90.2% |
| Q3 2016 | $5,666,000 | +30.5% | 84,500 | -42.0% | 0.06% | +38.6% |
| Q2 2016 | $4,343,000 | +110.3% | 145,800 | +107.4% | 0.04% | +193.3% |
| Q1 2016 | $2,065,000 | -42.7% | 70,300 | +52.8% | 0.02% | -31.8% |
| Q4 2015 | $3,606,000 | – | 46,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |